
iOnctura
iOnctura is a clinical-stage biopharmaceutical company focused on developing innovative, oral small molecule therapies for neglected and hard-to-treat cancers.
/10
Transparency ranking
Work at iOnctura?
Tell us what we're missing about working at iOnctura so we can make the job search more transparent for everyone.
Tell us what it's like to work at iOnctura!Description
iOnctura is a clinical-stage biopharmaceutical company focused on developing innovative treatments for neglected and hard-to-treat cancers. The company's mission is to extend lives and improve the quality of life for patients by pioneering bold new therapies that tackle cancer targets and types in novel ways. iOnctura's approach is based on precision oral small molecules that target cancers in a multi-pronged way, by directly preventing cancer cell proliferation, enhancing anti-tumor immune response, and inhibiting fibrotic processes.
iOnctura currently has two therapeutic candidates in mid-stage clinical development. Roginolisib, the first allosteric modulator of PI3Kδ, is being investigated for the treatment of uveal melanoma, non-small-cell lung cancer, primary myelofibrosis, and other cancers. Cambritaxestat, the only autotaxin inhibitor in clinical development to treat cancer, is being studied in combination with chemotherapy for pancreatic cancer and other solid tumors. iOnctura's commitment to patient-centric research and development is evident in its robust pipeline of innovative therapies.
Mission
iOnctura is a clinical-stage biopharmaceutical company focused on developing precision oral small molecules to combat neglected and hard-to-treat cancers. Their mission is to pioneer bold new treatments that address the unique needs of patients suffering from these challenging cancers, extending lives and improving healthspans, thereby changing the outlook for both patients and their families. Their focus on developing combination immunotherapies that synergistically enhance efficacy and overcome resistance mechanisms while prioritizing patient safety with a low-toxicity profile exemplifies their commitment to providing hope to those who need it most.
Culture
iOnctura promotes a culture focused on innovation and patient-centricity. They value collaboration across teams, embracing a data-driven approach to precision oncology. Their dedication to tackling neglected cancers and improving quality of life for patients is reflected in a supportive and empowering work environment that encourages bold ideas and passionate contributions from all employees.
Similar companies. But verified.
